Skip to main content

Advertisement

SpringerLink
Log in

The Role of Phosphatases in the Initiation of Skeletal Mineralization

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Endochondral ossification is a carefully orchestrated process mediated by promoters and inhibitors of mineralization. Phosphatases are implicated, but their identities and functions remain unclear. Mutations in the tissue-nonspecific alkaline phosphatase (TNAP) gene cause hypophosphatasia, a heritable form of rickets and osteomalacia, caused by an arrest in the propagation of hydroxyapatite (HA) crystals onto the collagenous extracellular matrix due to accumulation of extracellular inorganic pyrophosphate (PPi), a physiological TNAP substrate and a potent calcification inhibitor. However, TNAP knockout (Alpl –/–) mice are born with a mineralized skeleton and have HA crystals in their chondrocyte- and osteoblast-derived matrix vesicles (MVs). We have shown that PHOSPHO1, a soluble phosphatase with specificity for two molecules present in MVs, phosphoethanolamine and phosphocholine, is responsible for initiating HA crystal formation inside MVs and that PHOSPHO1 and TNAP have nonredundant functional roles during endochondral ossification. Double ablation of PHOSPHO1 and TNAP function leads to the complete absence of skeletal mineralization and perinatal lethality, despite normal systemic phosphate and calcium levels. This strongly suggests that the Pi needed for initiation of MV-mediated mineralization is produced locally in the perivesicular space. As both TNAP and nucleoside pyrophosphohydrolase-1 (NPP1) behave as potent ATPases and pyrophosphatases in the MV compartment, our current model of the mechanisms of skeletal mineralization implicate intravesicular PHOSPHO1 function and Pi influx into MVs in the initiation of mineralization and the functions of TNAP and NPP1 in the extravesicular progression of mineralization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Glimcher MJ (2006) Bone: nature of the calcium phosphate crystals and cellular, structural, and physical chemical mechanisms in their formation. Rev Mineral Geochem 64:223–282

    Article  CAS  Google Scholar 

  2. Anderson HC (1969) Vesicles associated with calcification in the matrix of epiphyseal cartilage. J Cell Biol 41:59–72

    Article  PubMed  CAS  Google Scholar 

  3. Ali SY, Sajdera SW, Anderson HC (1970) Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. Proc Natl Acad Sci USA 67:1513–1520

    Article  PubMed  CAS  Google Scholar 

  4. Anderson HC, Hsu HH, Morris DC, Fedde KN, Whyte MP (1997) Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol 151:1555–1561

    PubMed  CAS  Google Scholar 

  5. Register TC, McLean FM, Low MG, Wuthier RE (1986) Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. Effect of selective release of membrane-bound alkaline phosphatase and treatment with isosmotic pH 6 buffer. J Biol Chem 261:9354–9360

    PubMed  CAS  Google Scholar 

  6. Anderson HC (1995) Molecular biology of matrix vesicles. Clin Orthop Relat Res 314:266–280

    PubMed  Google Scholar 

  7. Golub EE (2009) Role of matrix vesicles in biomineralization. Biochim Biophys Acta 1790:1592–1598

    Article  PubMed  CAS  Google Scholar 

  8. Anderson HC, Garimella R, Tague SE (2005) The role of matrix vesicles in growth plate development and biomineralization. Front Biosci 10:822–837

    Article  PubMed  CAS  Google Scholar 

  9. Schinke T, McKee MD, Karsenty G (1999) Extracellular matrix calcification: where is the action? Nat Genet 21:150–151

    Article  PubMed  CAS  Google Scholar 

  10. Giachelli CM (2005) Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res 8:229–231

    Article  PubMed  CAS  Google Scholar 

  11. Millán J (2006) Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Wiley-VCH Verlag, Weinheim

    Book  Google Scholar 

  12. Houston B, Seawright E, Jefferies D, Hoogland E, Lester D, Whitehead C, Farquharson C (1999) Identification and cloning of a novel phosphatase expressed at high levels in differentiating growth plate chondrocytes. Biochim Biophys Acta 1448:500–506

    Article  PubMed  CAS  Google Scholar 

  13. Stewart AJ, Schmid R, Blindauer CA, Paisey SJ, Farquharson C (2003) Comparative modelling of human PHOSPHO1 reveals a new group of phosphatases within the haloacid dehalogenase superfamily. Protein Eng 16:889–895

    Article  PubMed  CAS  Google Scholar 

  14. Houston B, Stewart AJ, Farquharson C (2004) PHOSPHO1-A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage. Bone 34:629–637

    Article  PubMed  CAS  Google Scholar 

  15. Roberts SJ, Stewart AJ, Schmid R, Blindauer CA, Bond SR, Sadler PJ, Farquharson C (2005) Probing the substrate specificities of human PHOSPHO1 and PHOSPHO2. Biochim Biophys Acta 1752:73–82

    Article  PubMed  CAS  Google Scholar 

  16. Stefan C, Jansen S, Bollen M (2005) NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 30:542–550

    Article  PubMed  CAS  Google Scholar 

  17. Terkeltaub RA (2001) Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol Cell Physiol 281:C1–C11

    PubMed  CAS  Google Scholar 

  18. Bollen M, Gijsbers R, Ceulemans H, Stalmans W, Stefan C (2000) Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol 35:393–432

    Article  PubMed  CAS  Google Scholar 

  19. Terkeltaub R (2006) Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification. Purinergic Signal 2:371–377

    Article  PubMed  CAS  Google Scholar 

  20. Meyer JL (1984) Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231:1–8

    Article  PubMed  CAS  Google Scholar 

  21. Ho AM, Johnson MD, Kingsley DM (2000) Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289:265–270

    Article  PubMed  CAS  Google Scholar 

  22. Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millán JL, Terkeltaub R (2000) Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 279:R1365–R1377

    PubMed  CAS  Google Scholar 

  23. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millán JL (2002) Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA 99:9445–9449

    Article  PubMed  CAS  Google Scholar 

  24. Murshed M, Harmey D, Millán JL, McKee MD, Karsenty G (2005) Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19:1093–1104

    Article  PubMed  CAS  Google Scholar 

  25. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millán JL (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164:1199–1209

    Article  PubMed  CAS  Google Scholar 

  26. Whyte MP (2001) Hypophosphatasia. In: Scriver C, Beaudet A, Sly W, Valle D, Childs B, Kinzler K (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 5313–5329

    Google Scholar 

  27. Whyte MP (2012) Hypophosphatasia. In: Glorieux F, Jueppner H, Pettifor J (eds) Pediatric bone, 3rd edn. Elsevier (Academic Press), San Diego, pp 771–794

    Chapter  Google Scholar 

  28. Narisawa S, Frohlander N, Millán JL (1997) Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dyn 208:432–446

    Article  PubMed  CAS  Google Scholar 

  29. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millán JL, MacGregor GR, Whyte MP (1999) Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 14:2015–2026

    Article  PubMed  CAS  Google Scholar 

  30. Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millán JL (2004) Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164:841–847

    Article  PubMed  CAS  Google Scholar 

  31. Whyte MP (1994) Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 15:439–461

    PubMed  CAS  Google Scholar 

  32. Anderson HC, Harmey D, Camacho NP, Garimella R, Sipe JB, Tague S, Bi X, Johnson K, Terkeltaub R, Millán JL (2005) Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Am J Pathol 166:1711–1720

    Article  PubMed  CAS  Google Scholar 

  33. Roberts S, Narisawa S, Harmey D, Millán JL, Farquharson C (2007) Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization. J Bone Miner Res 22:617–627

    Article  PubMed  CAS  Google Scholar 

  34. Roberts SJ, Stewart AJ, Sadler PJ, Farquharson C (2004) Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem J 382:59–65

    Article  PubMed  CAS  Google Scholar 

  35. Stewart AJ, Roberts SJ, Seawright E, Davey MG, Fleming RH, Farquharson C (2006) The presence of PHOSPHO1 in matrix vesicles and its developmental expression prior to skeletal mineralization. Bone 39:1000–1007

    Article  PubMed  CAS  Google Scholar 

  36. MacRae VE, Davey MG, McTeir L, Narisawa S, Yadav MC, Millán JL, Farquharson C (2010) Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick. Bone 46:1146–1155

    Article  PubMed  CAS  Google Scholar 

  37. Huesa C, Yadav MC, Finnila MA, Goodyear SR, Robins SP, Tanner KE, Aspden RM, Millán JL, Farquharson C (2011) PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures. Bone 48:1066–1074

    Article  PubMed  CAS  Google Scholar 

  38. Yadav MC, Simao AM, Narisawa S, Huesa C, McKee MD, Farquharson C, Millán JL (2011) Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J Bone Miner Res 26:286–297

    Article  PubMed  CAS  Google Scholar 

  39. Robison R (1923) The possible significance of hexosephosphoric esters in ossification. Biochem J 17:286–293

    PubMed  CAS  Google Scholar 

  40. Majeska RJ, Wuthier RE (1975) Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochim Biophys Acta 391:51–60

    Article  PubMed  CAS  Google Scholar 

  41. Omelon S, Georgiou J, Henneman ZJ, Wise LM, Sukhu B, Hunt T, Wynnyckyj C, Holmyard D, Bielecki R, Grynpas MD (2009) Control of vertebrate skeletal mineralization by polyphosphates. PLoS One 4:e5634

    Article  PubMed  Google Scholar 

  42. Ciancaglini P, Yadav MC, Simao AM, Narisawa S, Pizauro JM, Farquharson C, Hoylaerts MF, Millán JL (2010) Kinetic analysis of substrate utilization by native and TNAP-, NPP1-, or PHOSPHO1-deficient matrix vesicles. J Bone Miner Res 25:716–723

    PubMed  CAS  Google Scholar 

  43. Suzuki A, Ghayor C, Guicheux J, Magne D, Quillard S, Kakita A, Ono Y, Miura Y, Oiso Y, Itoh M, Caverzasio J (2006) Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res 21:674–683

    Article  PubMed  CAS  Google Scholar 

  44. Wu LN, Sauer GR, Genge BR, Valhmu WB, Wuthier RE (2003) Effects of analogues of inorganic phosphate and sodium ion on mineralization of matrix vesicles isolated from growth plate cartilage of normal rapidly growing chickens. J Inorg Biochem 94:221–235

    Article  PubMed  CAS  Google Scholar 

  45. Wu LN, Genge BR, Kang MW, Arsenault AL, Wuthier RE (2002) Changes in phospholipid extractability and composition accompany mineralization of chicken growth plate cartilage matrix vesicles. J Biol Chem 277:5126–5133

    Article  PubMed  CAS  Google Scholar 

  46. Nielsen LB, Pedersen FS, Pedersen L (2001) Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone 28:160–166

    Article  PubMed  CAS  Google Scholar 

  47. Yoshiko Y, Candeliere GA, Maeda N, Aubin JE (2007) Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 27:4465–4474

    Article  PubMed  CAS  Google Scholar 

  48. Beck L, Leroy C, Beck-Cormier S, Forand A, Salaun C, Paris N, Bernier A, Urena-Torres P, Prie D, Ollero M, Coulombel L, Friedlander G (2010) The phosphate transporter PiT1 (Slc20a1) revealed as a new essential gene for mouse liver development. PLoS One 5:e9148

    Article  PubMed  Google Scholar 

  49. Polewski MD, Johnson KA, Foster M, Millán JL, Terkeltaub R (2010) Inorganic pyrophosphatase induces type I collagen in osteoblasts. Bone 46:81–90

    Article  PubMed  CAS  Google Scholar 

  50. Silver FH, Landis WJ (2011) Deposition of apatite in mineralizing vertebrate extracellular matrices: a model of possible nucleation sites on type I collagen. Connect Tissue Res 52:242–254

    Article  PubMed  CAS  Google Scholar 

  51. McNally EA, Schwarcz HP, Botton GA, Arsenault AL (2012) A model for the ultrastructure of bone based on electron microscopy of ion-milled sections. PLoS One 7:e29258

    Article  PubMed  CAS  Google Scholar 

  52. Millán JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, Gramatikova S, Terkeltaub R, Camacho NP, McKee MD, Crine P, Whyte MP (2008) Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res 23:777–787

    Article  PubMed  Google Scholar 

  53. Foster BL, Nagatomo KJ, Tso HW, Tran AB, Niciti FH, Narisawa S, McKee MD, Millán JL, Somerman MJ (2012) Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res. doi:10.1002/jbmr.1767

  54. Foster BL, Nagatomo KJ, Nociti FH Jr, Fong H, Dunn D, Tran AB, Wang W, Narisawa S, Millán JL, Somerman MJ (2012) Central role of pyrophosphate in acellular cementum formation. PLoS One 7(6):e38393

    Article  PubMed  CAS  Google Scholar 

  55. McKee MD, Nakano Y, Masica DL, Gray JJ, Lemire I, Heft R, Whyte MP, Crine P, Millán JL (2011) Enzyme replacement therapy prevents dental defects in a model of hypophosphatasia. J Dent Res 90:470–476

    Article  PubMed  CAS  Google Scholar 

  56. Yadav MC, de Oliveira RC, Foster BL, Fong H, Cory E, Narisawa S, Sah RL, Somerman M, Whyte MP, Millán JL (2012) Enzyme replacement prevents enamel defects in hypophosphatasia mice. J Bone Miner Res 27:1722–1734

    Article  PubMed  CAS  Google Scholar 

  57. Kapustin AN, Davies JD, Reynolds JL, McNair R, Jones GT, Sidibe A, Schurgers LJ, Skepper JN, Proudfoot D, Mayr M, Shanahan CM (2011) Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 109:e1–e12

    Article  PubMed  CAS  Google Scholar 

  58. Narisawa S, Harmey D, Yadav MC, O’Neill WC, Hoylaerts MF, Millán JL (2007) Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res 22:1700–1710

    Article  PubMed  CAS  Google Scholar 

  59. Lomashvili KA, Garg P, Narisawa S, Millán JL, O’Neill WC (2008) Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int 73:1024–1030

    Article  PubMed  CAS  Google Scholar 

  60. Kiffer-Moreira T, Yadav MC, Zhu D, Narisawa S, Sheen C, Stec B, Cosford ND, Dahl R, Farquharson C, Hoylaerts MF, MacRae VE, Millán JL (2012) Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J Bone Miner Res. doi:10.1002/jbmr.1733

Download references

Acknowledgement

The author’s work cited in this review has been supported by grants DE12889, AR53102, and AR47908 from the National Institutes of Health.

Author information

Authors and Affiliations

  1. Sanford Children’s Health Research Center, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA, 92037, USA

    José Luis Millán

Authors
  1. José Luis Millán
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José Luis Millán.

Additional information

The author has stated that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Millán, J.L. The Role of Phosphatases in the Initiation of Skeletal Mineralization. Calcif Tissue Int 93, 299–306 (2013). https://doi.org/10.1007/s00223-012-9672-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-012-9672-8

Keywords

Search

Navigation